Get the latest local stories in your inbox.
Science, Tech & Medicine in ...
Marvell is reportedly closing in on an all-stock deal for Lumentum, whose laser capacity is sold out through 2029.
Pixclara is an FDA-approved brain imaging drug intended to help distinguish recurrent or progressive glioma from treatment-related changes.
The Palo Alto company is building on Lean, the proof system also drawing interest from Anthropic and OpenAI.
NASA Ames engineers in Mountain View use a towering motion simulator to rehearse a 2028 lunar touchdown, astronaut Doug Wheelock says it shaped his own training.
Four volunteers at Johnson Space Center grew crops and dodged email delays to help NASA plan real Mars missions.
New limits on iodine, manganese and vitamins A and D could reshape every can on store shelves nationwide.
Builders spent a month tackling factory and supply-chain problems before showing off finished projects at Moonshot's Fort Worth headquarters.
Scientists say debris from the May superbolide may still sit in a 1.9-by-2.3-mile patch of Cape Cod Bay.
Young Liu says talks with OpenAI are underway, as Foxconn's Houston server plants eye more expansion.
The new Biosafety Level 3 lab will include four dedicated research suites and two animal research suites, replacing OHSU's current two-workspace facility.
ATI Robotics builds its haulers in Bangalore today, but it's betting a Madison Heights base will put it next to Detroit's supply chain.
The Baldwin Fund wants to lure top cancer researchers to Syracuse and land federal designation for Upstate's cancer center.
Johnston-Willis Hospital is merging gamma knife and focused ultrasound under one roof so patients can get scanned and treated the same day.
Please enable JavaScript to select your regional newsletters and subscribe.
Choose one or more regions. Get the latest local stories when there is news to share.
Select the local newsletters you’d like to receive, then subscribe.
0 regions selected
No matching regions. Try another search.
Free. Unsubscribe anytime. Daily when new stories are available.
Open the standalone signup form
Subscribe to Hoodline newsletters